Identifying breast cancer risk using imaging and genetic information
Radiomic and genomic predictors of breast cancer risk
This study is looking at how new imaging methods and genetic information can help predict breast cancer risk in women, so that those at higher risk can get more personalized care and monitoring while avoiding unnecessary tests for those at lower risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10991301 on NIH RePORTER |
What this research studies
This research investigates how advanced imaging techniques and genetic information can be combined to better predict breast cancer risk in women. By analyzing features from mammograms and using genetic risk scores, the study aims to create more accurate models that can identify women at high risk for breast cancer. This personalized approach could lead to tailored screening regimens, allowing high-risk women to receive more intensive monitoring while reducing unnecessary screenings for those at lower risk. The research will involve a large cohort of women from diverse backgrounds to ensure broad applicability of the findings.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are at risk for breast cancer, particularly those with a family history or other risk factors.
Not a fit: Patients who are not at risk for breast cancer or those who have already been diagnosed with the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer screening strategies, ultimately saving lives.
How similar studies have performed: Previous research has shown promise in using imaging and genetic data for cancer risk prediction, but this specific approach is novel and has not been independently validated.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Sieh, Weiva — University of Tx Md Anderson Can Ctr
- Study coordinator: Sieh, Weiva
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.